Leap Therapeutics Inc (NASDAQ:LPTX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - LPTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - LPTX

  • Market Cap$124.090m
  • SymbolNASDAQ:LPTX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS52187K1016

Company Profile

Leap Therapeutics Inc is a biopharmaceutical company. The company is acquiring and developing novel therapeutics at the leading edge of cancer biology. Its programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the body's immune system to identify and attack cancer. Leap has two clinical stage programs: DKN-01 and TRX518. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1, or DKK1, a protein that regulates important cell signaling pathways, known as the Wnt pathways. TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR, a receptor found on the surface of a wide range of immune cells.Leap Therapeutics Inc is a biopharmaceutical company . The company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

Latest LPTX news

Currently there for this company. Visit our news hub for other news .